Anuh Pharma Limited (ANUHPHR) Ratios

1 Followers

Anuh Pharma Limited Ratios

IN:ANUHPHR's free cash flow for Q2 2025 was ₹0.22. For the 2025 fiscal year, IN:ANUHPHR's free cash flow was decreased by ₹ and operating cash flow was ₹0.05. See a summary of the company’s cash flow.

Ratios	TTM	Mar 24	Mar 23	Mar 22
Liquidity Ratios
Current Ratio	2.11	2.11	2.22	1.91
Quick Ratio	1.45	1.69	1.72	1.46
Cash Ratio	0.01	0.11	0.05	0.01
Solvency Ratio	0.29	0.31	0.44	0.28
Operating Cash Flow Ratio	0.07	0.21	0.08	0.33
Short-Term Operating Cash Flow Coverage	0.00	3.54	6.42	0.00
Net Current Asset Value	₹ 1.97B	₹ 1.96B	₹ 1.84B	₹ 1.44B
Leverage Ratios
Debt-to-Assets Ratio	<0.01	0.02	<0.01	<0.01
Debt-to-Equity Ratio	<0.01	0.03	<0.01	<0.01
Debt-to-Capital Ratio	<0.01	0.03	<0.01	<0.01
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00
Financial Leverage Ratio	1.56	1.55	1.53	1.68
Debt Service Coverage Ratio	133.39	5.10	29.15	211.07
Interest Coverage Ratio	127.94	91.78	191.36	203.52
Debt to Market Cap	0.00	0.01	<0.01	0.00
Interest Debt Per Share	0.06	1.15	0.30	0.11
Net Debt to EBITDA	-0.03	-0.12	-0.05	-0.02
Profitability Margins
Gross Profit Margin	20.96%	24.51%	24.78%	23.89%
EBIT Margin	7.34%	9.32%	12.16%	9.04%
EBITDA Margin	8.79%	10.64%	13.48%	10.88%
Operating Profit Margin	6.67%	8.59%	10.46%	8.43%
Pretax Profit Margin	7.29%	9.22%	12.10%	9.00%
Net Profit Margin	5.45%	7.16%	9.28%	6.86%
Continuous Operations Profit Margin	5.45%	7.16%	9.28%	6.86%
Net Income Per EBT	74.71%	77.62%	76.69%	76.22%
EBT Per EBIT	109.39%	107.33%	115.73%	106.80%
Return on Assets (ROA)	8.22%	9.35%	13.48%	8.93%
Return on Equity (ROE)	12.81%	14.52%	20.62%	15.00%
Return on Capital Employed (ROCE)	15.56%	17.32%	23.10%	18.24%
Return on Invested Capital (ROIC)	11.62%	13.02%	17.57%	13.90%
Return on Tangible Assets	8.22%	9.35%	13.48%	8.94%
Earnings Yield	5.23%	6.14%	5.38%	3.24%
Efficiency Ratios
Receivables Turnover	3.26	3.05	3.39	3.07
Payables Turnover	3.68	3.18	3.46	2.63
Inventory Turnover	5.13	6.70	6.45	5.53
Fixed Asset Turnover	12.45	10.96	13.14	9.91
Asset Turnover	1.51	1.31	1.45	1.30
Working Capital Turnover Ratio	3.87	3.45	3.90	3.85
Cash Conversion Cycle	83.97	59.37	58.90	46.03
Days of Sales Outstanding	112.10	119.57	107.72	118.88
Days of Inventory Outstanding	71.10	54.44	56.55	66.04
Days of Payables Outstanding	99.23	114.64	105.38	138.88
Operating Cycle	183.20	174.01	164.27	184.92
Cash Flow Ratios
Operating Cash Flow Per Share	1.22	3.70	1.29	5.38
Free Cash Flow Per Share	-0.58	1.69	0.79	5.22
CapEx Per Share	1.80	2.01	0.50	0.15
Free Cash Flow to Operating Cash Flow	-0.48	0.46	0.61	0.97
Dividend Paid and CapEx Coverage Ratio	0.37	1.14	0.86	5.23
Capital Expenditure Coverage Ratio	0.68	1.84	2.58	34.77
Operating Cash Flow Coverage Ratio	53.60	3.41	4.80	59.45
Operating Cash Flow to Sales Ratio	0.02	0.06	0.02	0.10
Free Cash Flow Yield	-0.73%	2.20%	0.71%	4.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	19.11	16.28	18.60	30.87
Price-to-Sales (P/S) Ratio	1.04	1.17	1.73	2.12
Price-to-Book (P/B) Ratio	2.44	2.36	3.83	4.63
Price-to-Free Cash Flow (P/FCF) Ratio	-136.58	45.39	141.21	21.33
Price-to-Operating Cash Flow Ratio	65.58	20.76	86.41	20.72
Price-to-Earnings Growth (PEG) Ratio	2.38	-0.77	0.28	1.68
Price-to-Fair Value	2.44	2.36	3.83	4.63
Enterprise Value Multiple	11.81	10.83	12.75	19.44
Enterprise Value	7.98B	7.62B	11.12B	11.16B
EV to EBITDA	11.81	10.83	12.75	19.44
EV to Sales	1.04	1.15	1.72	2.12
EV to Free Cash Flow	-136.29	44.88	140.64	21.31
EV to Operating Cash Flow	65.44	20.53	86.06	20.70
Tangible Book Value Per Share	32.61	32.52	29.04	24.06
Shareholders’ Equity Per Share	32.62	32.53	29.06	24.07
Tax and Other Ratios
Effective Tax Rate	0.25	0.22	0.23	0.24
Revenue Per Share	76.60	66.00	64.56	52.63
Net Income Per Share	4.17	4.72	5.99	3.61
Tax Burden	0.75	0.78	0.77	0.76
Interest Burden	0.99	0.99	1.00	1.00
Research & Development to Revenue	0.00	0.00	0.00	0.00
SG&A to Revenue	0.03	<0.01	<0.01	<0.01
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00
Income Quality	0.31	0.61	0.17	1.14

Currency in INR